Larry McMillan Stock Market Update Video 10/06/2025
By Lawrence G. McMillan
Join Larry McMillan as he discusses the current state of the stock market on October 6, 2025.
Join Larry McMillan as he discusses the current state of the stock market on October 6, 2025.
New Delhi, Markets regulator Sebi has proposed raising the threshold for identifying High Value Debt Listed Entities (HVDLEs) to Rs 1,000 crore from Rs 500 crore at present to reduce compliance burdens. Currently, an entity having outstanding value of listed non-convertible debt securities of Rs 500 crore and above are referred to as ‘High Value…
The Indian market ended higher on Tuesday, lifted by advances in financial and IT stocks, after U.S. President Donald Trump delayed the rollout of new tariffs to August 1 and imposed fresh levies on several trading partners but signalled that a trade deal with India was near, saying the two countries were “close to a…
Companies that provide consumer products and services, particularly food, beverage, and other consumables, are suitable for long-term investors. Five TSX consumer staple stocks are defensive holdings because of demand stability regardless of the economic environment. Top performer Maple Leaf Foods (TSX:MFI) outperforms thus far in 2025. At $24.92 per share, current investors enjoy a +23.7%…
November 23, 2011 Ausgold Loses Its Chief Executive, But Not Its Focus On The World Class Katanning Gold Discovery By Our Man in Oz Source >> www.minesite.com/aus.html It would be exaggerating to call Benjamin Bell a A$20 million man, but that is the value the market appears to have put on the recently departed…
Our biggest risk, at all times, is market risk. What I mean by this is your whole portfolio – and mine – being vulnerable to a big bear market. Think a 50% drawdown like 2008. We can make our future decisions much easier…by avoiding a bear market as much as possible! Here’s one idea on…
Aurinia Pharmaceuticals (AUPH) has recently gained attention in the market due to a series of positive developments. The company’s financial performance in Q1 2024 showed remarkable growth, with total net revenue increasing by 46% year-over-year to $50.3 million. This article This small biotech stock is on fire! Aurinia Pharmaceuticals just reported a 46% revenue jump…